Molecular Partners AG is a Swiss biotechnology company based in Schlieren near Zürich. It develops therapeutic proteins based on its proprietary DARPin technology, notably in oncology. Its shares are listed on the SIX Swiss Exchange and Nasdaq.
Date confirmed from the company's own report as filed with the U.S. SEC on Form 6-K.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Molecular Partners is scheduled to report its next quarterly earnings on 10/29/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Molecular Partners last reported quarterly earnings on 8/25/2026 (Q2 2026). Earnings per share (EPS) came in at -0.35 CHF.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.